Fig 4.

 Patient with inflammatory breast carcinoma (Table 2, patient 3), effect of the vaccine on the skin lesions. (A) Prevaccine. The arrow points to the area where the biopsy was taken to generate the vaccine. (B) 15 days after the beginning of vaccine administration. (C) 30 days after the beginning of vaccine administration. (D) 60 days after the beginning of vaccine administration. (E) 90 days after the beginning of vaccine administration. (F) 180 days after the beginning of vaccine administration